VieCure, Inc. today announced the closing of its $25 million Series A growth equity investment, led by Northpond Ventures. An undisclosed investor is also contributing to the round. VieCure, an oncology clinical informatics company with an artificial intelligence (AI) enabled clinical decision support platform, will use the new funding to accelerate the deployment of its next generation clinical decision support solution, and grow the sales and business development organization in response to the expanding pipeline and partnering opportunities in the life sciences arena
Who to call at VieCure, and when
A new round usually means VieCure is about to hire and buy. The teams that reach out first get the meeting.
An alert the day VieCure raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at VieCure, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
VieCure
Location
Greenwood Village, Colorado, United States
About
VieCure is a leading provider of intelligent software platforms for oncology care, focused on democratizing access to precision medicine in community cancer care practices. Their Halo Intelligence™ platform supports clinics by providing real-time access to critical information, enhancing clinical decision-making through AI and workflow automation. With nearly 30,000 patients managed and a growing national network, VieCure aims to improve operational efficiency and quality of care in oncology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VieCure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.